AA
PTLA

ALPS Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

ALPS Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-138,825
Closed -$990K – 845
2020
Q1 		$990K Sell
138,825
-14,888
-10% -$186K 0.02% 275
2019
Q4 		$3.67M Buy
+153,713
New +$4.24M 0.03% 182
2018
Q2 		– Sell
-87,516
Closed -$2.86M – 982
2018
Q1 		$2.86M Buy
87,516
+15,210
+21% +$667K 0.02% 186
2017
Q4 		$3.52M Buy
72,306
+15,518
+27% +$785K 0.02% 156
2017
Q3 		$3.07M Buy
56,788
+5,320
+10% +$312K 0.02% 165
2017
Q2 		$2.89M Buy
51,468
+2,823
+6% +$113K 0.02% 163
2017
Q1 		$1.91M Sell
48,645
-5,691
-10% -$181K 0.01% 180
2016
Q4 		$1.22M Sell
54,336
-17,693
-25% -$346K 0.01% 203
2016
Q3 		$1.64M Sell
72,029
-7,299
-9% -$171K 0.01% 196
2016
Q2 		$1.87M Buy
79,328
+16,013
+25% +$395K 0.02% 173
2016
Q1 		$1.29M Sell
63,315
-10,233
-14% -$325K 0.01% 175
2015
Q4 		$3.78M Sell
73,548
-8,727
-11% -$423K 0.04% 134
2015
Q3 		$35.1K Buy
82,275
+30,616
+59% +$1.48M 0.04% 133
2015
Q2 		$2.35M Buy
51,659
+27,464
+114% +$1.1M 0.02% 156
2015
Q1 		$918K Buy
+24,195
New +$831K 0.01% 187

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

ALPS Advisors's PTLA Position: Q2 2020 in Review

ALPS Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 138,825 shares — an estimated $990K sold.

ALPS Advisors first reported a position in PTLA in Q1 2015 and held it in 15 quarters. The position peaked at $3.78M in Q4 2015. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • ALPS Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • ALPS Advisors sold 138,825 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $990K.
  • ALPS Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 15 quarters.
  • ALPS Advisors's Portola Pharmaceuticals, Inc. position peaked at $3.78M in Q4 2015.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on ALPS Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.